ArticleAesthetic plastic surgery2025
Nerve Block-Assisted Intradermal Injection of Tranexamic Acid, Vitamin C, and Glutathione for Melasma: A Split-Face Comparative Study.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMelasma is a common acquired pigmentary disorder characterized by symmetrical hyperpigmented macules. However, combination therapy using tranexamic acid (TXA), vitamin C, and glutathione under nerve block remains inadequate.
objectiveTo evaluate the efficacy and safety of intradermal injection of TXA, vitamin C, and glutathione under nerve block for melasma treatment.
methodsA prospective, split-face trial was conducted on 20 patients with melasma during November 2023-July 2024. Lidocaine cream was applied to one side of the face, while infraorbital and zygomaticofacial nerve blocks were applied to the other. Intradermal injections of TXA, vitamin C, and glutathione were administered at weeks 2, 4, 6, and 8. Efficacy was assessed before treatment and three months post-treatment.
resultsVISIA analysis showed significant increases in UV spots and brown spots (P < 0.001), indicating improved skin condition. Modified Melasma Area and Severity Index (mMASI) scores decreased significantly from 6.99 ± 1.62 to 4.50 ± 1.27 (P < 0.001). Visual analog scale (VAS) pain scores were higher on to topical anesthesia side (4.35 ± 1.22) compared to the nerve block side (2.50 ± 0.83) (P < 0.001). No severe adverse events were reported.
conclusionIntradermal injection of TXA, vitamin C, and glutathione under nerve block is an effective, safe, and low-pain treatment for melasma. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors https://www.springer.com/00266 .
Indexed as
Identifiers
40835769What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.